The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines

British Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 822-831

  Reichert, T E ^b,d   Kashii, Y ^b   Stanson, J ^b   Zeevi, A ^a   Whiteside, T L ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antisense IL 2 oligonucleotides; Apoptosis; Human carcinomas; IL 2; IL 2 IL 2R pathway; Tumour cell growth

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; RAPAMYCIN; TACROLIMUS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIGAND BINDING; LYMPHOCYTE; MITOSIS; PRIORITY JOURNAL;

ANTIBODIES; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-2; JURKAT CELLS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, INTERLEUKIN-2; SIROLIMUS; STOMACH NEOPLASMS; TACROLIMUS; TUMOR CELLS, CULTURED;

EID: 0008879952     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690770     Document Type: Article

References (37)

1. Alileche A, Plaisance S, Han DS, Rubinstein E, Mingari C, Bellomo R, Jasmin C and Azzarone B (1993) Human melanoma cell line M14 secretes a functional interleukin-2. Oncogene 8: 1791-1796
2. Arzi E, Stelzer G, Renner U, Lange M, Mullar OA and Staffa GK (1992) Interleukin 2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures, J Clin Invest 90: 1944-1955
3. Capcacioli S, diPasquale G, Mini E, Mazzi T and Quatrone A (1993) Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. biochem. Biochem Biophys Res Commun 197: 818-825
4. Chen K, Demetris AJ, VanThiel DH and Whiteside TL (1987) Double immunoenzyme staining method for analysis of tissue and blood lymphocyte subsets with monoclonal antibodies. Lab Invest 56: 114-119
5. Chomezynski P and Sacci N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
6. Ciacci C, Mahida YR, Dignass A, Koizumi M and Podolsky DK (1993) Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest 92: 527-532
7. Damjanovich S, Bene L, Matko J, Alileche A, Goldman CK, Sharrow S, Waldmann TA (1997) Preassembly of interleukin-2 receptor subunits on resting Kit 225 K6 T cells and their modulating by IL-2, IL-7, and IL-12. A fluorescence resonance energy transfer study. Proc Natl Acad Sci 94: 13134-13139
8. Degols G, Leonetti JP, Mechti N and Lebleu B (1991) Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene. Nucleic Acid Res 19: 945-948
9. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH and Cosman D (1995) IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leuk Biol 57: 763-766
10. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M and et al (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Sceince 264: 965-968
11. Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka RB, Barnes EL, Johnson JT, Herberman RB and Whiteside TL (1989) Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Canrer Res 49: 5167-5175
12. Hesslan J-MJ, Branellec AI, Pilatte Y, Lang P and Lagruec G (1991) Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal change nephrotic syndrome. Clin Exp Immunol 86: 157-162
13. Kalman VK and Klimpel GR (1981) Cyclosporin A inhibits the production of gamma interferon (IFN-γ) but does not inhibit production of virus-induced Interferon α/β. Cell Immunol 78: 122-129
14. Lin WC, Yasamura S, Suminami Y, Sung MW, Nagashima S, Stanson J and Whiteside TL (1995) Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth, J Immunol 155: 4805-4816
15. McMillan DN, Kernohan NM, Flett ME, Heys SD, Deehan DJ, Sewell HF, Walker F and Eremin O (1995) Interleukin-2 receptor expression and interleukin-2 localization in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumor cell proliferation. Int J Cancer 60: 766-772
16. Nagashima S, Kashii Y, Reichert TE, Suminami Y, Suzuki T and Whiteside TL (1997a) Human gastric carcinoma transduced with the IL-2 gene: Increased sensitivity to immune effector cells in vitro and in vivo, Int J Cancer 72: 174-183
17. Nagashima S, Reichert TE, Kashii Y, Suminami Y, Chikamatsu K and Whiteside TL (1997b) In vitro characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Cancer Gene Therapy 4: 366-376
18. Nakanishi K, Hirose S, Yoshimoto T, Ishizashi H, Hiroishi K, Tanaka T, Kono T, Miyasaka M, Taniguchi T and Higashino K (1992) Role and regulation of interleukin (IL)-2 receptor alpha and beta chains in IL-2-driven B-cell growth. Proc Natl Acad Sci USA 89: 3351-3555
19. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massaque J, Crabtree GR and Roberts JM (1994) Interleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573
20. Plaisance S, Rubinstein E, Alileche A, Sahraoui Y, Krief P, Augery-Bourget Y, Jasmin C. Suarez H and Azzarone B (1992) Expression of the interleukin-2 receptor on human fibroblasts and its biological significance. Int Immunol 4: 739-746
21. Plaisance S, Rubinstein E, Alileche A, Benoit P, Jasmin C and Azzarone B (1993) The IL-2 receptor present on human embryonic fibroblasts is functional in the absence of P64/IL-2R gamma chain. Int Immunol 5: 843-848
22. Rabinowich H, Vitolo D, Altarac S, Herberman RB and Whiteside TL (1992) Role ot cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer hy human IL-2-activated natural killer cells. J Immunol 149: 140-349
23. Reichert TE, Nagashima S, Kashii Y, Stanson J, Don QP and Whiteside TL (1998a) Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression, Proc AACR 39: 152
24. Reichert TE. Watkins S, Stanson J, Johnson TJ and Whiteside TL (1998b) Endogenous IL-2 in cancer cells: a marker of cellular proliferation. J Histochem Cytochem 46: 603-611
25. Rimoldi D, Sulvi S, Hartmann F, Scheyer M, Blum S, Zografos L, Plaisance S, Azzarone B and Carrel S (1993) Expression of IL-2 receptors in human melanoma tells. Anticancer Res 13: 555-564
26. Sander B, Andersson J and Andersson U (1991) Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Res 119: 65-93
27. Saneto RP, Altman A, Knobler RL, Johnson HM and De Vellis Y (1986) Interleukin-2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro, Proc Natl Acad Sci USA 83: 9221-9225
28. Schreiber SL (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283-287
29. Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB and Whiteside TL (1991) Characterization of human autotumor-active T cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Turner Res 51: 6153-6162
30. Stein CA and Cheng YC (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261: 1004-1-12
31. Suminami Y, Kashii Y, Law JC, Lin W-C, Stanson J, Reichert TE, Rabinowich H and WhitesideTL (1998) Molecular analysis of the IL-2 receptor β chain gene expressed in human tumor cells. Oncogene 16: 1309-1317
32. Taniguchi T and Minami Y (1993) The IL-2/IL-2 receptor system: a current overview. Cell 73: 5-8
33. Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J and Gelfand EW (1993) Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late GI phase of the cycle. J Cell Physiol 154: 7-15
34. Waldmann TA (1991) The interleukin-2 receptor. J Biol Chem 266: 2681-2684
35. Weidmann E, Sacchi M, Plaisance S, Heo DS, Yasamura S, Lin WC, Johnson JT, Herberman RB, Azzarone B and Whiteside TL (1992) Receptors for interleukin-2 on human squamous cell carcinoma cell lines and tumor in situ. Cancer Res 52: 5963-5970
36. Whiteside TL, Sung M-W, Nagashima S, Chikamatsu K, Okada K and Vujanovic NL (1998) Human tumor antigen-specific T lymphocytes and IL-2 activated natural killer (A-NK) cells; Comparisons of antitumor effects in vitro and in vivo. Clin Cancer Res 4: 1135-1145
37. Yasumura S, Lin WC, Weidmann E, Hebda P and Whiteside TL (1994) Expression of interleukin-2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2. Int J Cancer 59: 225-234